- All abstracts must be submitted electronically by the appropriate deadlines. Click here for list of deadlines.
- An individual may submit as many abstracts as he/she wishes. NEW THIS YEAR, nonmembers may submit abstracts without the sponsorship of a member, but there is a higher fee for submission. ASCB members receive special pricing for abstract submission.
- All material must be the work of authors listed and appropriately referenced. The submitting author must provide Conflict of Interest Disclosure information and have read and agreed to the ASCB Abstract License and Publishing Agreement for ALL authors when submitting an abstract.
- Word Count: The abstract text is limited to 2,800 characters, including spaces (~400 words). This limit includes the body of the abstract only. The abstract title is limited to 200 character, including spaces. If your abstract exceeds these limits, you will be prompted to reduce the characters under these limits before being allowed to continue. NEW THIS YEAR, there is a character count provided on the abstract title and text submission page that shows you how many characters you have entered.
Reasons for Rejection
While it is rare for an abstract not to be accepted, ASCB reserves the right—at its sole discretion—to reject any abstract deemed inappropriate. To help ensure abstract acceptance:
- Make sure your abstract includes results. Whether new findings presented in an abstract are experimental or theoretical, specific results MUST be included. The results, whether experimental or calculated, must be stated in the abstract. An author is free to include his or her latest data in the final poster presented at the meeting, but the results included in the original abstract must be substantive.
- Avoid promotion of a commercial product or service. The Abstract Program Committee tries to ensure ASCB poster sessions are not used as venues for commercial promotion. The ASCB will NOT accept abstracts that promote a specific product without providing new biological insight. Statements like, “We show that X product works better than Y product” are clear indicators of promotion and will be cause for rejection. In contrast, an abstract that presents findings of interest to cell biologists, but mentions that the work was done with a proprietary and copyrighted product, and co-authors include those at the company who made the product, may be deemed acceptable.
Notifications will be sent to the submitting author only (not the presenting author). It is that individual’s responsibility to share the notification with the other authors on the abstract.
After a successful abstract submission, the submitting author will receive a notification stating the abstract has been successful submitted, in addition to an email receipt.
Acceptance and rejection notifications will be sent via email to the submitting author and timing is based on the following schedule:
- Individuals who submit an abstract by the August 5 deadline will be notified no later than September 3 if they are selected to present a talk in a Minisymposium; and no later than September 25 if they are selected to present an ePoster talk or poster presentation.
- Individuals who submit an abstract by the September 3 deadline will be notified no later than September 25 if they are selected to present in a poster presentation.
- Individuals who submit an abstract by the October 16 deadline will be notified no later than October 27 if they are selected to present in a poster presentation.
The first email received by poster presenters will indicate if the poster was accepted, and provide the submitting author with the session title and date. All poster presenters will receive a second email in early November with the full details of their poster, including board number, presentation number (for identification and citation purposes), and instructions on how to upload your poster for viewing during the meeting by other attendees (optional). Click here for more information on uploading your poster.
If you do NOT receive a notification by the dates listed above corresponding to your abstract submission, please contact email@example.com.